Breed Reply Invests in METRON and TAG Sensors
The two companies raised a total of £3.75 million from Breed Reply and other investors. These new investments mean Breed Reply’s pan-European investment portfolio of early stage IoT businesses has increased to 20 in a variety of different sectors, including health, industrial IoT, smart buildings and cities, and transportation.
METRON increases Breed Reply’s focus on industrial IoT technology. Energy is a significant cost in many industries and METRON’s technology provides industrial clients with an intelligent network that can better manage energy usage.
The technology provides the virtual mapping of the energy used in industrial processes and big data analytics to allow companies to be predictive and proactive in energy efficiency. By using artificial intelligence and control capabilities, METRON’s platform communicates directly with energy markets and decentralized energy assets to optimise operations in real-time according to context. Its customers include leading manufacturing companies from a variety of energy-intensive industries and METRON also partners with facility managers, utilities and OEMs in Europe, Latin America and the Middle-East.
TAG Sensors platform also offers significant benefits to customers, particularly in the pharmaceutical and food industries, including McDonald’s, where temperature control of goods is vital to ensure product quality. TAG Sensors has developed a market-leading technology using radio-frequency identification (RFID). For the first time, it is possible to have continuous real-time temperature logging of individual products required to be kept at specific temperatures such as food and vaccines. In the food industry, an estimated $813 billion is lost each year globally from poor cold-chain management and the pharmaceutical industry loses an estimated $12.5 billion per annum due to temperature fluctuations of products in shipping and storage.
Both METRON and TAG Sensors meet Breed Reply’s investment criteria of companies that combine strong management teams with an innovative technology that solves a real-world problem.
As well as funding, Breed Reply will work closely with management to accelerate both companies’ development to achieve Series A funding and beyond. Last year, one-third of Breed Reply’s portfolio raised more than $50 million of Series A funding.
The Breed Reply team has significant experience in scaling up early-stage businesses, in-depth understanding of different markets, proven track record in sales channel development and strong technological DNA. They also work closely with Reply Group, a leading consulting, systems integration and digital services company with a market presence all over Europe and the USA to help the investee companies commercialise their products.
Emanuele Angelidis, CEO of Breed Reply, said: “METRON and TAG Sensors are fantastic additions to our investment portfolio. As well as strong management, they have business ideas with long-term potential and technologies that companies are looking for. There is a considerable market for TAG Sensors low cost, versatile and highly-automated solution to the problem of cold-chain management and METRON’s ability to deliver improved energy efficiency to lower costs and meet ever stricter environmental regulations is vital for a multitude of industries. We are looking forward to supporting them to achieve their ambitions.”
Vincent Sciandra, CEO, METRON said: “This new funding will support the international growth of METRON and increase our ability to roll-out our highly successful energy intelligence platform. Over the last five years, we have helped companies across a variety of industries turn energy efficiency from a static, reactive process into a dynamic, proactive strategy. We are reshaping the way energy data is used. It is a strong endorsement of our technology and potential that Breed Reply has backed us and we look forward to working with them.”
Knut Nygard, CEO, TAG Sensors, said: “There is increasing global demand for our complete solution for cold chain management from leading companies in both the pharmaceutical and food industries. Major brands such as McDonald’s have tested and adopted our system in recent years and this new funding will enable us to expand and make our system available to more and more customers. The addition of Breed Reply as an investor, with its expertise in helping IoT companies scale-up and continued support of Platform Ventures will help us grow, invest more in innovation and seek opportunities in other sensor-based market segments.”
About Breed Reply
Breed Reply, Reply's active operational investor, funds and supports the development of early-stage companies in the Internet of Things (IoT) in Europe and the USA. Based in London, with operational offices in Germany and Italy, Breed Reply supports entrepreneurs and young talent by quickly bringing new ideas to the market. This is done via three fundamental services: funding at early-stage level; active operational involvement with significant know how transfer of business, managerial and technological expertise; and go-to-market support through the extensive Reply network. Breed Reply’s focus is the Internet of Things over all markets, with their current portfolio in Health, Fitness & Wellness, Smart Building & Cities, Security, Industrial IoT, Big Data, Platforms and Drones.www.breedreply.com
Founded in 2013, METRON has developed an energy intelligence platform to help industrial factories become energy transparent. By harnessing multiple sources of data generated by industrial systems, METRON Energy Virtual Assistant leverages latest machine learning capabilities and dedicated knowledge bases to proactively identify energy savings opportunities, connect to decentralised energy resources and turn energy into a profit centre. The company has more than 40 experts, data scientists and energy engineers, who help industrial clients in all sectors to maximise value from their energy data and support them with the implementation of energy efficiency optimisations.
About TAG Sensors
TAG Sensors is a complete cold-chain logistics solution for the food and pharmaceutical industries. It has developed the first low-cost, full visibility solution that ensures and proves that temperature sensitive foods and pharmaceutical products have been stored and transported within the temperature limits.
TAG Sensors radio-frequency identification (RFID) temperature logger label is the only one on the market that can effectively track temperature and other variables of an individual package from production to consumption, ensuring transparency, improving quality control and minimising wastage due to improper handling.
Redleaf Communications for Breed Reply
Robin Tozer / Ian Silvera
+44 (0)20 3757 6865
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Takeda Receives Positive CHMP Opinion Recommending ALUNBRIG® (brigatinib) for the Treatment of ALK+ Non-Small Cell Lung Cancer in Patients Previously Treated with Crizotinib21.9.2018 13:30 | Pressemelding
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending the full approval of ALUNBRIG® (brigatinib) as a monotherapy for the treatment of adult patients with anaplastic lymphoma kinase-positive (ALK+) advanced non-small cell lung cancer (NSCLC) previously treated with crizotinib. ALUNBRIG is a tyrosine kinase inhibitor (TKI) designed to target and inhibit the ALK mutation in NSCLC. Approximately three to five percent of NSCLC patients globally have the ALK mutation. If the CHMP opinion is affirmed, and the European Commission approves ALUNBRIG, it will become the only ALK inhibitor available in the European Union as a one tablet per day dose that can be taken with or without food. The randomized, global Phase 2 ALTA trial was designed to investigate the efficacy and safety of ALUNBRIG in patients with locally advanced or metastatic ALK+
Asda Selects HCL Technologies to Help Drive IT Transformation21.9.2018 12:16 | Pressemelding
HCL Technologies (HCL), a leading global technology company, today announced that it has been selected to help drive IT transformation at the UK’s third-largest grocery retailer, Asda. The three-year application services contract will see HCL transform Asda’s IT Application Services with a new DevOps delivery model to drive data and analytics and support back-office applications through the full lifecycle of development, testing and support. HCL will also build a central data management platform to enable Asda to improve its insight and analytics capabilities. Asda operates more than 600 stores across the UK, employing over 135,000 people. Asda wanted to adopt a more agile approach towards application development and testing. This would allow the company to respond faster to business requirements and reduce time to market, while driving better user experience and satisfaction. HCL was selected due to its extensive expertise in successfully delivering similar large scale IT transformati
Ipsen Receives Positive CHMP Opinion for Cabometyx® (Cabozantinib) for the Second-line Treatment of Patients with Hepatocellular Carcinoma (HCC)21.9.2018 05:30 | Pressemelding
Regulatory News: Ipsen (Euronext:IPN; ADR:IPSEY) announced today that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), provided a positive opinion for Cabometyx® (cabozantinib) as a monotherapy for the treatment of hepatocellular carcinoma (HCC) in adults who have been previously treated with sorafenib. The CHMP positive opinion will now be reviewed by the European Commission (EC), which has the authority to approve medicines for the European Union (EU). Alexandre Lebeaut, MD, Executive Vice President, R&D and Chief Scientific Officer, Ipsen, said: “The global burden of liver cancer is increasing and despite the recent introduction of new agents, it remains the second leading cause of cancer mortality worldwide. Following today’s positive CHMP opinion and if approved by the European Commission, Cabometyx ® as monotherapy will give patients with HCC a much-needed new oral therapeutic option.” Dr Lorenza Rimassa,
Quanergy Selected as Exclusive LiDAR Partner for VRCO21.9.2018 05:00 | Pressemelding
Quanergy Systems, Inc., a global leader in the design and development of solid state LiDAR sensors and smart sensing solutions, and VRCO, designer and manufacturer of the luxury high-end e-VTOL (electric Vertical Take-Off and Landing) craft, the NeoXcraft XP2, today announced that VRCO will exclusively use Quanergy’s S3 solid state LiDAR sensors in the testing and market release versions of the aircraft. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180920006036/en/ VRCO NeoXcraft XP2 with Quanergy S3 LiDAR Sensor (Graphic: Business Wire) The NeoXcraft XP2, which VRCO and the University of Derby unveiled in late 2017 and intend to launch in 2020, is a two-passenger e-VTOL high-speed land, air, and water capable craft. The craft can scan and memorize take-off locations and store the data for use on the next approach to the same location. Quanergy’s innovative S3 solid state LiDAR sensor will be used for downward and forward
Overseas Roadshow for the IAPH Guangzhou 2019 World Ports Conference Was Held in London21.9.2018 03:08 | Pressemelding
Overseas roadshow for the IAPH Guangzhou 2019 World Ports Conference was successfully held in Armourer's Hall, London, UK on September 20th. Ms. Yuan Yue, Deputy Director General of Guangzhou Port Authority, met with over 100 senior representatives from British ports, ship-owners, commodity traders, shipping & service companies, shipping public policy research institutes, and other representatives from the port and shipping industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180920006031/en/ Speech made by Lord Jeffrey Evans, Chairman of Maritime London (Photo: Business Wire) In her keynote speech, Ms. Yuan Yue said, “Guangzhou is the gateway city of South China and is known as the “Millennium Business Capital” and a popular destination for business and investment. At present, Guangzhou has attracted investors from over 130 countries. Nearly 300 of the world's top 500 companies have businesses and investment in Guangzho
AbuDhabi Dubai STOB Series 22 Investment Enters into Favorable Tender Offer Agreement with MINDOL HOLDINGS21.9.2018 01:00 | Pressemelding
AbuDhabi Dubai STOB Series 22 Investment Limited Partnership, hereafter AbuDhabi22, and MINDOL HOLDINGS LIMITED, hereafter MINDOL, listed on the Hong Kong-based Coinsuper exchange (https://www.coinsuper.com) have reached an agreement where AbuDhabi22 will acquire the minimum 33.3 percent holding for the MINDOL cryptocurrency (MIN, https://mindol.net) to be issued by MINDOL, via a tender offer (TOB). Implementation of the TOB will serve to strengthen the strategic partnership with MINDOL. Both companies expect that the AbuDhabi22 bid will greatly exceed any bids made via ordinary exchange channels. With a bid offering at a stable price, the TOB method was chosen for its strategic worth. The MINDOL business vision for 2019 sets a target for its cryptocurrency, from among the more than 2,000 types of cryptocurrencies currently available, to have a top-30 market capitalization. As a business that focuses on "the fusion of subculture and blockchain," they will develop an online game that ta